These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Microbiota-accessible pectic poly- and oligosaccharides in gut health. Tingirikari JMR Food Funct; 2018 Oct; 9(10):5059-5073. PubMed ID: 30280147 [TBL] [Abstract][Full Text] [Related]
31. Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders. Huaman JW; Mego M; Manichanh C; Cañellas N; Cañueto D; Segurola H; Jansana M; Malagelada C; Accarino A; Vulevic J; Tzortzis G; Gibson G; Saperas E; Guarner F; Azpiroz F Gastroenterology; 2018 Oct; 155(4):1004-1007. PubMed ID: 29964041 [TBL] [Abstract][Full Text] [Related]
32. A reverse metabolic approach to weaning: in silico identification of immune-beneficial infant gut bacteria, mining their metabolism for prebiotic feeds and sourcing these feeds in the natural product space. Michelini S; Balakrishnan B; Parolo S; Matone A; Mullaney JA; Young W; Gasser O; Wall C; Priami C; Lombardo R; Kussmann M Microbiome; 2018 Sep; 6(1):171. PubMed ID: 30241567 [TBL] [Abstract][Full Text] [Related]
33. High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. Monteagudo-Mera A; Arthur JC; Jobin C; Keku T; Bruno-Barcena JM; Azcarate-Peril MA Benef Microbes; 2016; 7(2):247-64. PubMed ID: 26839072 [TBL] [Abstract][Full Text] [Related]
34. Dietary fibers as beneficial microbiota modulators: A proposed classification by prebiotic categories. Rezende ESV; Lima GC; Naves MMV Nutrition; 2021 Sep; 89():111217. PubMed ID: 33838493 [TBL] [Abstract][Full Text] [Related]
35. Weight gain by gut microbiota manipulation in productive animals. Angelakis E Microb Pathog; 2017 May; 106():162-170. PubMed ID: 27836763 [TBL] [Abstract][Full Text] [Related]
36. Prebiotic Potential of a Maize-Based Soluble Fibre and Impact of Dose on the Human Gut Microbiota. Costabile A; Deaville ER; Morales AM; Gibson GR PLoS One; 2016; 11(1):e0144457. PubMed ID: 26731113 [TBL] [Abstract][Full Text] [Related]
37. Functional oligosaccharide fermentation in the gut: Improving intestinal health and its determinant factors-A review. Zhang N; Jin M; Wang K; Zhang Z; Shah NP; Wei H Carbohydr Polym; 2022 May; 284():119043. PubMed ID: 35287885 [TBL] [Abstract][Full Text] [Related]
38. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study. Chu JR; Kang SY; Kim SE; Lee SJ; Lee YC; Sung MK World J Gastroenterol; 2019 Oct; 25(40):6129-6144. PubMed ID: 31686768 [TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of prebiotic effects of four oligosaccharides using in vitro gut model: digestibility, microbiome, and metabolome changes. Cheon S; Kim G; Bae JH; Lee DH; Seong H; Kim DH; Han JS; Lim SY; Han NS FEMS Microbiol Ecol; 2023 Jan; 99(2):. PubMed ID: 36623850 [TBL] [Abstract][Full Text] [Related]